Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Anti-GUCY2C chimeric antigen receptor T-cell (Immunochina) in stomach adenocarcinoma: NCT07406984 Clinical Landscape Report 2026
16 October 2026
NCT07406984 clinical landscape for stomach adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin in Albuminuria: NCT07405216 Clinical Landscape Report 2026
16 October 2026
NCT07405216 clinical landscape for Albuminuria: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tislelizumab in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07408609 Clinical Landscape Report 2026
16 October 2026
NCT07408609 clinical landscape for Locally Advanced Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context a…
9 min read
Megestrol Acetate in Cachexia: NCT07408505 Clinical Landscape Report 2026
16 October 2026
NCT07408505 clinical landscape for Cachexia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BT-409 in Parkinson Disease: ACTRN12626000191392 Clinical Landscape Report 2026
16 October 2026
ACTRN12626000191392 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DGPR1008 in Prostatic Cancer: NCT07415135 Clinical Landscape Report 2026
16 October 2026
NCT07415135 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
225 Ac-rhPSMA-10.1 in Metastatic castration-resistant prostate cancer: NCT07414940 Clinical Landscape Report 2026
16 October 2026
NCT07414940 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Ocankitug in Pulmonary Disease, Chronic Obstructive: NCT07418736 Clinical Landscape Report 2026
16 October 2026
NCT07418736 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
VGN-R08 in Parkinson Disease: NCT07414290 Clinical Landscape Report 2026
16 October 2026
NCT07414290 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HSK-39004 in Pulmonary Disease, Chronic Obstructive: NCT07425210 Clinical Landscape Report 2026
16 October 2026
NCT07425210 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Eloralintide in Kidney Failure, Chronic: NCT07426380 Clinical Landscape Report 2026
16 October 2026
NCT07426380 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
QX-031N in Pulmonary Disease, Chronic Obstructive: ISRCTN22936350 Clinical Landscape Report 2026
16 October 2026
ISRCTN22936350 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development w…